Baidu
map

指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

胆道肿瘤临床实践指南（英文第三版）

2021-04-25 中华消化外科杂志.2021.20(4):359-375.

胆道肿瘤

英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。

中文标题：

胆道肿瘤临床实践指南（英文第三版）

发布机构：

发布日期：

2021-04-25

简要介绍：

英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。

相关资料下载：
[AttachmentFileName(sort=1, fileName=胆道肿瘤临床实践指南（英文第三版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=04c1c1c002108154, title=胆道肿瘤临床实践指南（英文第三版）, enTitle=, guiderFrom=中华消化外科杂志.2021.20(4):359-375., authorId=0, author=, summary=英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。, cover=https://img.medsci.cn/2021529/1622302429150_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Apr 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。</p> </div> </div> </div>, tagList=[TagDto(tagId=2871, tagName=胆道肿瘤)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2871, guiderKeyword=胆道肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5100, appHits=94, showAppHits=0, pcHits=443, showPcHits=5006, likes=4, shares=9, comments=5, approvalStatus=1, publishedTime=Sun May 30 00:27:55 CST 2021, publishedTimeString=2021-04-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 29 23:33:56 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 07:52:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=胆道肿瘤临床实践指南（英文第三版）.pdf)])
胆道肿瘤临床实践指南（英文第三版）.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-10-07 14898059m33暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-09-30 wquick

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-07-09 ljqLJQ

    好好学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-05 ori丶

    来学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-04 药生尘8738

    感谢

    0

拓展阅读

胆道肿瘤患者的营养治疗共识

中国抗癌协会肿瘤营养与支持治疗专业委员会 · 2021-06-09

Baidu
map
Baidu
map
Baidu
map